Skip to content

Genpact LTD

G· NYSECore metricsCIK 1398659

Management consulting services59 peers

Last sale
Nov 12, 2026 · -1.09%
Market cap
$7.21B
167.23M shares
Filings
1,049
$1.39B
Q3 2026+6.6% FY25 yoy
$151.66M
Q3 2026+7.6% FY25 yoy
$210.98M
Q3 2026+6.9% FY25 yoy
$87.47M
Q3 2026derived+37.9% FY25 yoy
$0.89
Q3 2026+9.8% FY25 yoy
$499.05M
Q3 2026+31.7% FY25 yoy
$7.21B
12.3×
1.3×
2.7×
4.94%
1.72%

Twelve months to Sep 30, 2026 · derived

Price

$43.133.93%$1.77past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$5.08BFY 2025
$5.08B0FY 2013FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$5,079,879,000reported
FY 20242024-12-31$4,767,139,000reported
FY 20232023-12-31$4,476,888,000reported
FY 20222022-12-31$4,371,172,000reported
FY 20212021-12-31$4,022,211,000reported
FY 20202020-12-31$3,709,377,000reported
FY 20192019-12-31$3,520,543,000reported
FY 20182018-12-31$3,000,790,000reported
FY 20172017-12-31$2,736,929,000reported
FY 20162016-12-31$2,570,756,000reported
FY 20142014-12-31$2,279,438,000reported
FY 20132013-12-31$2,131,997,000reported

Capital returns

Dividends and buybacks · FY2015 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$117.75M—$117.75M$0.68169.86M sh−3.3%16.0%
FY2024$108.47M$252.67M$361.14M$0.61175.67M sh−2.8%67.8%
FY2023$100.01M$225.50M$325.51M$0.55180.73M sh−1.8%74.8%
FY2022$91.84M$214.08M$305.92M$0.50183.98M sh−0.6%77.8%
FY2021$80.48M$298.22M$378.70M$0.43185.17M sh−1.6%59.1%

Segments

Revenue by Segments, FY2019 to FY2025FY2019BCMI · FY2019 · $1.08BCGRLH · FY2019 · $1.11BHMS · FY2019 · $1.35BFY2020High Tech and Manufacturing · FY2020 · $1.39BConsumer and Healthcare · FY2020 · $1.26BFinancial Services · FY2020 · $1.08BBCMI · FY2020 · $1.08BCGRLH · FY2020 · $1.26BHMS · FY2020 · $1.39BFY2021High Tech and Manufacturing · FY2021 · $1.49BConsumer and Healthcare · FY2021 · $1.52BFinancial Services · FY2021 · $1.02BBCMI · FY2021 · $1.02BCGRLH · FY2021 · $1.51BHMS · FY2021 · $1.48BFY2022High Tech and Manufacturing · FY2022 · $1.62BConsumer and Healthcare · FY2022 · $1.59BFinancial Services · FY2022 · $1.16BFY2023High Tech and Manufacturing · FY2023 · $1.68BConsumer and Healthcare · FY2023 · $1.57BFinancial Services · FY2023 · $1.23BFY2024High Tech and Manufacturing · FY2024 · $1.79BConsumer and Healthcare · FY2024 · $1.69BFinancial Services · FY2024 · $1.29BFY2025High Tech and Manufacturing · FY2025 · $2.00BConsumer and Healthcare · FY2025 · $1.72BFinancial Services · FY2025 · $1.36B
LineFY2025ShareChange
High Tech and Manufacturing$2.00B39%+11.9%
Consumer and Healthcare$1.72B34%+1.9%
Financial Services$1.36B27%+5.3%
BCMI———
CGRLH———
HMS———
Total$5.08B

From the 10-K filed Feb 26, 2026G

Management consulting services

Genpact LTD is the 2nd largest of the 60 covered companies the SEC files under this code, by revenue. SIC 8742

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Genpact LTD · CIK 1398659 · Engraved from SEC EDGAR